Stratos Wealth Partners, LTD.
Position in PHAT — Phathom Pharmaceuticals, Inc.
CIK 1612865
BEACHWOOD, OH
Position in PHAT
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,085,000
-$26,000 QoQ
Shares Held
100,000
0.0% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#60
of 161 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Stratos Wealth Partners, LTD. holds $14,445,280 across 20 Biotechnology names. PHAT ranks #4 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZVRA |
Zevra Therapeutics, Inc.
|
408,000 | $5,850,720 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,267 | $1,622,816 | |
| 3 | PLX |
Protalix BioTherapeutics, Inc.
|
500,000 | $1,165,000 | |
| 4 | PHAT |
Phathom Pharmaceuticals, Inc.
This page
|
100,000 | $1,085,000 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
7,801 | $618,541 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
1,382 | $513,647 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
6,603 | $491,791 | |
| 8 | GANX |
Gain Therapeutics, Inc.
|
200,000 | $406,000 |
All Filings in PHAT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,085,000 | 100,000 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,111,000 | 100,000 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $834,477 | 50,300 | Shares | Sole | 2026-01-20 | |
| No filing history on record for this holder in this stock. | ||||||